Cargando…
When should iron supplementation in dialysis patients be avoided, minimized or withdrawn?
Parenteral iron is used to restore the body's iron pool before and during erythropoiesis‐stimulating agent (ESA) therapy; together these agents form the backbone of anemia management in end‐stage renal disease (ESRD) patients undergoing hemodialysis. ESRD patients receiving chronic intravenous...
Autor principal: | Rostoker, Guy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379289/ https://www.ncbi.nlm.nih.gov/pubmed/29956370 http://dx.doi.org/10.1111/sdi.12732 |
Ejemplares similares
-
Iatrogenic Iron Overload in Dialysis Patients at the Beginning of the 21st Century
por: Rostoker, Guy, et al.
Publicado: (2016) -
Re: Further Evidence Supporting the Accuracy of Quantitative Magnetic Resonance Imaging for Evaluating Iron Load in Dialysis Patients
por: Rostoker, Guy, et al.
Publicado: (2017) -
Reassessment of Iron Biomarkers for Prediction of Dialysis Iron Overload: An MRI Study
por: Rostoker, Guy, et al.
Publicado: (2015) -
Differential Pharmacokinetics of Liver Tropism for Iron Sucrose, Ferric Carboxymaltose, and Iron Isomaltoside: A Clue to Their Safety for Dialysis Patients
por: Rostoker, Guy, et al.
Publicado: (2022) -
Hepatic Iron Load at Magnetic Resonance Imaging Is Normal in Most Patients Receiving Peritoneal Dialysis
por: Issad, Belkacem, et al.
Publicado: (2017)